The prediction performance of continuous wavelet-transformed 12-lead hs-ECG (MyovistaTM, HeartSciences) with time–frequency-energy displays (Fig. 1A) for diagnosing the echocardiographic features of diastolic dysfunction was validated using machine-learning approaches with receiver-operating characteristic curves (ROC).
Partho P. Sengupta, Hemant Kulkarni, Allen J. Weiss, Negin Nezarat, Ahmad Mahmoud, Dong Li, Marilyn Graves, Ahmed Rashid, Alaa Omar, Matthew Budoff, Jagat Narula
HeartSciences’ AI-ECG products are currently in development and not commercially available in the United States.
wavECG and wavEKG are trademarks of HeartSciences.
MV-WBSTE-002 Rev A